REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 64 filers reported holding REPROS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,445,000 | +3.9% | 329,030 | 0.0% | 0.72% | +27.3% |
| Q2 2015 | $2,353,000 | -16.7% | 329,030 | 0.0% | 0.56% | -22.3% |
| Q1 2015 | $2,826,000 | -13.8% | 329,030 | 0.0% | 0.73% | -17.8% |
| Q4 2014 | $3,280,000 | -68.6% | 329,030 | -68.8% | 0.88% | -66.2% |
| Q3 2014 | $10,431,000 | -4.8% | 1,053,600 | +66.4% | 2.62% | -27.9% |
| Q2 2014 | $10,957,000 | +49.6% | 633,350 | +53.5% | 3.63% | +0.4% |
| Q1 2014 | $7,322,000 | +89.0% | 412,726 | +94.9% | 3.62% | +40.6% |
| Q4 2013 | $3,875,000 | – | 211,729 | – | 2.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |